Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer - Fig 3

<p>(A) Kaplan-Meier curves of progression-free survival (RFS) in patients with intravesical treatment patients (green) and no treatment patients (blue) in no residual tumor group after repeated transurethral resection of bladder tumor (re-TURBT). Two-year PFS was 69.6% and 57.5%, respectively, for the different treatment categories (p = 0.328). (B) Kaplan-Meier curves of PFS in patients with intravesical treatment patients (green) and no treatment patients (blue) in residual tumor group after re-TURBT. Two-year RFS was 41.7% and 31.5%, respectively, for the different treatment categories (p = 0.008).